REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Condor Pharma (Кондор Фарма ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Condor Pharma Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Condor Pharma (Кондор Фарма ЕООД) is based in Bulgaria. The head office is in Lozen. The enterprise currently operates in the Pharmacies and Drug Stores sector. Condor Pharma (Кондор Фарма ЕООД) was incorporated on September 13, 2026. 3 (2024) employees currently work for Condor Pharma (Кондор Фарма ЕООД). From the latest financial highlights, Condor Pharma (Кондор Фарма ЕООД) reported a net sales revenue increase of 15.12% in 2024. There was a total growth of 25.76% in Condor Pharma (Кондор Фарма ЕООД)’s total assets over the same period. The enterprise’s net profit margin increased by 0.77% in 2024.

Headquarters
Lozen
Lozen; Sofiya (stolitsa); Postal Code: 1151

Contact Details: Purchase the Condor Pharma (Кондор Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Condor Pharma (Кондор Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Condor Pharma (Кондор Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Condor Pharma (Кондор Фарма ЕООД) report to view the information.
Incorporation Date:
September 13, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Condor Pharma (Кондор Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.12%▲
Total Operating Revenue
15.39%▲
Operating Profit
28.33%▲
EBITDA
23.57%▲
Net Profit/Loss for the Period
26.13%▲
Total Assets
25.76%▲
Total Equity
47.41%▲
Operating Profit Margin
1%▲
Net Profit Margin
0.77%▲
Return on Equity (ROE)
-13.82%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo